Consistently, in vivo experiments showed a decrease in melanoma growth after NRAS depletion, associated with the suppression of Ras/RAF/MEK/ERK and PI3K/Akt pathways (Liu S. et al., 2017). This evidence concerns the gene MAP2K7 and melanoma.